Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 24393989)

1.

[A case of carcinoma associated with anal fistula effectively treated with preoperative chemoradiotherapy].

Nishigaki T, Murata K, Okubo H, Mikami K, Okamura S, Wada Y, Kato R, Makino S, Okada K, Fukuchi N, Ebisui C, Kinuta M.

Gan To Kagaku Ryoho. 2013 Nov;40(12):1990-2. Japanese.

PMID:
24393989
2.

[A case of carcinoma associated with anal fistula in which reconstruction using a gracilis musculocutaneous flap was performed after preoperative chemoradiotherapy].

Ishigame T, Momma T, Suzuki S, Nakamura I, Ohki S, Koyama Y, Suzuki S, Takenoshita S.

Gan To Kagaku Ryoho. 2012 Nov;39(12):1957-9. Japanese.

PMID:
23267942
3.

[Laparoscopic abdominoperineal resection after preoperative chemoradiotherapy for advanced carcinoma associated with anal fistula].

Morikawa T, Yamashita K, Sumi Y, Kanemitsu K, Yamamoto M, Kanaji S, Imanishi T, Nakamura T, Suzuki S, Tanaka K, Kakeji Y.

Gan To Kagaku Ryoho. 2014 Nov;41(12):1875-7. Japanese.

PMID:
25731360
4.

[Neoadjuvant chemoradiotherapy with capecitabine and oxaliplatin for the treatment of locally advanced lower rectal cancer].

Murata K, Okamura S, Okubo H, Owada Y, Nishigaki T, Wada Y, Kato R, Makino S, Takeoka T, Okada K, Fukuchi N, Ebisui C, Kinuta M.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2020-2. Japanese.

PMID:
24393999
5.

[A case of carcinoma associated with anal fistula resected after preoperative chemoradiotherapy].

Sato Y, Ohki S, Sassa M, Tachibana K, Ando J, Endo Y, Suzuki S, Nakamura I, Koyama Y, Suzuki S, Takenoshita S.

Gan To Kagaku Ryoho. 2011 Aug;38(8):1341-3. Japanese.

PMID:
21829077
6.

A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.

Zhao L, Bai C, Shao Y, Guan M, Jia N, Xiao Y, Qiu H, Zhang F, Yang T, Zhong G, Chen S.

Cancer Lett. 2011 Nov 28;310(2):134-9. doi: 10.1016/j.canlet.2011.06.026. Epub 2011 Jul 5.

PMID:
21782322
7.

[A case report of locally advanced rectal carcinoma effectively treated with preoperative chemoradiotherapy].

Kitani K, Okajima K, Kimura H, Ikeda M, Inoue K, Iwama M, Nakayama T, Fujiwara Y, Murata M, Yukawa M, Ishikawa K, Ota Y, Inoue M.

Gan To Kagaku Ryoho. 2010 Nov;37(12):2635-7. Japanese.

PMID:
21224663
8.

Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study.

Nogué M, Salud A, Vicente P, Arriví A, Roca JM, Losa F, Ponce J, Safont MJ, Guasch I, Moreno I, Ruiz A, Pericay C; AVACROSS Study Group.

Oncologist. 2011;16(5):614-20. doi: 10.1634/theoncologist.2010-0285. Epub 2011 Apr 5.

9.

[A case report of metastatic anal fistula cancer treated with neoadjuvant chemotherapy].

Murata A, Takatsuka S, Shinkawa H, Kaizaki R, Hori T, Ikehara T.

Gan To Kagaku Ryoho. 2014 Nov;41(12):1869-71. Review. Japanese.

PMID:
25731358
10.

A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma.

Zhu J, Gu W, Lian P, Sheng W, Cai G, Shi D, Cai S, Zhang Z.

Radiat Oncol. 2013 May 29;8:130. doi: 10.1186/1748-717X-8-130.

11.
12.

Fistula-associated anal adenocarcinoma: good results with aggressive therapy.

Gaertner WB, Hagerman GF, Finne CO, Alavi K, Jessurun J, Rothenberger DA, Madoff RD.

Dis Colon Rectum. 2008 Jul;51(7):1061-7. doi: 10.1007/s10350-008-9294-4. Epub 2008 Apr 17.

PMID:
18418652
13.

[A case of primary carcinoma associated with anal fistula].

Nushijima Y, Nakano K, Sugimoto K, Nakaguchi K, Kan K, Maruyama H, Doi S, Okamura S, Murata K.

Gan To Kagaku Ryoho. 2014 Nov;41(12):1872-4. Japanese.

PMID:
25731359
14.

[A case of total pelvic exenteration and reconstruction of perianal skin defect using a VY advancement of bilateral gluteus maximus musculocutaneous flaps for anal canal cancer associated with anal fistula].

Ikenaga M, Miyazaki M, Yasui M, Mishima H, Tsujie M, Miyamoto A, Hirao M, Fujitani K, Nakamori S, Yoshitatsu S, Tsujinaka T.

Gan To Kagaku Ryoho. 2010 Nov;37(12):2650-2. Japanese.

PMID:
21224668
15.

Implantation of rectal cancer in an anal fistula: report of a case.

Ishiyama S, Inoue S, Kobayashi K, Sano Y, Kushida N, Yamazaki Y, Yanaga K.

Surg Today. 2006;36(8):747-9.

PMID:
16865523
16.

Oncologic outcome after preoperative chemoradiotherapy in patients with pathologic T0 (ypT0) rectal cancer.

Jang TY, Yu CS, Yoon YS, Lim SB, Hong SM, Kim TW, Kim JH, Kim JC.

Dis Colon Rectum. 2012 Oct;55(10):1024-31. doi: 10.1097/DCR.0b013e3182644334.

PMID:
22965400
17.

Phase II study of bevacizumab and chemoradiation in the preoperative or adjuvant treatment of patients with stage II/III rectal cancer.

Spigel DR, Bendell JC, McCleod M, Shipley DL, Arrowsmith E, Barnes EK, Infante JR, Burris HA 3rd, Greco FA, Hainsworth JD.

Clin Colorectal Cancer. 2012 Mar;11(1):45-52. doi: 10.1016/j.clcc.2011.04.002. Epub 2011 Aug 15.

PMID:
21840771
18.

[Perianal mucinous adenocarcinoma. A further reason for histological study of anal fistula or anorectal abscess].

Marti L, Nussbaumer P, Breitbach T, Hollinger A.

Chirurg. 2001 May;72(5):573-7. German.

PMID:
11383070
19.

The "sliding door" technique for closure of abdominal wall defects after rectus abdominis musculocutaneous flap transposition.

Nakamoto T, Koyama F, Kobata Y, Nagao M, Nakagawa T, Nakamura S, Ueda T, Nishigori N, Inoue T, Kawasaki K, Obara S, Fujii H, Kido A, Koizumi M, Tanaka Y, Nakajima Y.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2430-2.

PMID:
24394135
20.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk